Clover Health Confirms NASDAQ Listing for CLOV Stock

Ticker: CLOV · Form: 8-K · Filed: Jan 10, 2024 · CIK: 1801170

Clover Health Investments, Corp. /De 8-K Filing Summary
FieldDetail
CompanyClover Health Investments, Corp. /De (CLOV)
Form Type8-K
Filed DateJan 10, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: regulatory-filing, compliance, stock-listing

TL;DR

**Clover Health's 8-K is a routine filing confirming its NASDAQ listing, no new news.**

AI Summary

Clover Health Investments, Corp. filed an 8-K on January 10, 2024, primarily to disclose that its Class A Common Stock, with a par value of $0.0001 per share, is registered on The NASDAQ Stock Market LLC under the symbol CLOV. This filing is a routine update, indicating no significant operational or financial changes. For investors, this means the company continues to meet its basic SEC reporting obligations, which is a positive sign of regulatory compliance, but it doesn't provide new information to alter investment decisions.

Why It Matters

This filing confirms Clover Health's continued compliance with SEC regulations and its listing on NASDAQ, providing transparency and liquidity for investors.

Risk Assessment

Risk Level: low — This 8-K is a standard administrative filing and does not introduce new risks or material changes to the company's operations or financial health.

Analyst Insight

A smart investor would recognize this as a routine compliance filing that doesn't offer new material information for investment decisions, and would look for more substantive filings like 10-Qs or 10-Ks for financial performance updates.

Key Numbers

  • $0.0001 — Par Value per Share (the stated par value of Clover Health's Class A Common Stock)

Key Players & Entities

  • CLOVER HEALTH INVESTMENTS, CORP. (company) — the registrant filing the 8-K
  • The NASDAQ Stock Market LLC (company) — the exchange where Clover Health's stock is registered
  • CLOV (company) — the trading symbol for Clover Health's Class A Common Stock
  • $0.0001 (dollar_amount) — the par value per share of Class A Common Stock
  • January 10, 2024 (date) — the date of the earliest event reported in the 8-K

Forward-Looking Statements

  • Clover Health will continue to be listed on The NASDAQ Stock Market LLC. (CLOVER HEALTH INVESTMENTS, CORP.) — high confidence, target: 2025-01-10

FAQ

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant as specified in its charter is CLOVER HEALTH INVESTMENTS, CORP.

What is the trading symbol for Clover Health's Class A Common Stock?

The trading symbol for Clover Health's Class A Common Stock is CLOV.

On which exchange is Clover Health's Class A Common Stock registered?

Clover Health's Class A Common Stock is registered on The NASDAQ Stock Market LLC.

What is the par value per share of Clover Health's Class A Common Stock?

The par value per share of Clover Health's Class A Common Stock is $0.0001.

What was the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported in this 8-K filing was January 10, 2024.

Filing Stats: 589 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2024-01-10 08:31:57

Key Financial Figures

  • $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On December 18, 2023, Clover Health Investments, Corp. (the "Company") issued a press release announcing that its Chief Executive Officer, Andrew Toy, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 12:00 p.m. Eastern Time. A live webcast of the presentation will be accessible through the investor relations section of the Company's website. The slide presentation to be used during the presentation is attached hereto as Exhibit 99.2 and incorporated herein by reference. On January 10, 2024, the Company issued a press release, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information set forth in this Item 7.01 (including Exhibit 99.1 and Exhibit 99.2) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press release dated January 10, 2024 99.2 Slide Presentation dated January 10, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Clover Health Investments, Corp. Date: January 10, 2024 By: /s/ Scott J. Leffler Name: Scott J. Leffler Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.